Since 2016, Elligo Health Research, an integrated research organization (IRO) founded by John Potthoff, Ph.D., and Chad Moore, has accelerated the development of new pharmaceutical, biotechnology, medical device and diagnostic products using our novel clinical technology and our Goes Direct® . Recognizing the challenges of clinical research, Elligo united the best clinical experts with the best research infrastructure – creating the ultimate clinical trial solution. It is our mission to ensure that all patients have access to clinical trials as a care option by maintaining the integrity of the trusted patient and physician relationship and building global communities of research leveraging electronic health records. In doing so, we expand the base of physicians and their patients who otherwise would not participate in clinical trials.